NEW YORK (GenomeWeb News) — Sequenom today said third-quarter revenues increased 43 percent as R&D spending rose 16 percent and losses decreased by 16 percent.
Total receipts for the three months ended Sept. 30 increased to $6.5 million from $4.6 million year over year.
R&D spending increased to $3 million from $2.6 million year over year.
The company said losses declined to $5.3 million from $6.3 million in the year-ago period.